{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:48:34Z","timestamp":1791884914925,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100209","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:25:40Z","timestamp":1787934340000},"page":"100209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelial indoleamine 2,3-dioxygenase 1 drives high-tryptophan diet\u2013mediated thrombosis in cancer-bearing mice"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-9386","authenticated-orcid":false,"given":"Asha","family":"Jose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Lotfollahzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0838-5913","authenticated-orcid":false,"given":"Anna","family":"Natrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7431-6301","authenticated-orcid":false,"given":"Arjun","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashvi","family":"Sethuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6127-9319","authenticated-orcid":false,"given":"Kylla","family":"Przekop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Del Carmen Piqueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arathi","family":"Ranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-8331","authenticated-orcid":false,"given":"Howard J.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-3024","authenticated-orcid":false,"given":"Katya","family":"Ravid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-6058","authenticated-orcid":false,"given":"Vipul C.","family":"Chitalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10203","key":"10.1016\/j.bvth.2026.100209_bib1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.bvth.2026.100209_bib2","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.bvth.2026.100209_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10080271","article-title":"The role of direct oral anticoagulants in treatment of cancer-associated thrombosis","volume":"10","author":"Al-Samkari","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bvth.2026.100209_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and venous thromboembolic disease: a review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.bvth.2026.100209_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100123","article-title":"Mechanisms of cancer-associated thrombosis","volume":"7","author":"Hisada","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bvth.2026.100209_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12959-025-00719-7","article-title":"Cancer-associated venous thromboembolism: a comprehensive review","volume":"23","author":"Wan","year":"2025","journal-title":"Thromb J"},{"issue":"26","key":"10.1016\/j.bvth.2026.100209_bib8","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood.2019001675","article-title":"Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis","volume":"134","author":"Belghasem","year":"2019","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.bvth.2026.100209_bib9","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1182\/bloodadvances.2025017079","article-title":"Dietary tryptophan augments cancer-associated venous thrombogenicity mitigated by indoleamine 2,3-dioxygenase 1 inhibition","volume":"9","author":"Lotfollahzadeh","year":"2025","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.bvth.2026.100209_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/sdi.12255","article-title":"Thrombosis in the uremic milieu--emerging role of \u201cthrombolome\u201d","volume":"28","author":"Shashar","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/j.bvth.2026.100209_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111295","article-title":"The emerging roles of IDO2 in cancer and its potential as a therapeutic target","volume":"137","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.bvth.2026.100209_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.bvth.2026.100209_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5482\/HAMO-14-10-0052","article-title":"The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. an emerging field","volume":"35","author":"Polyzos","year":"2015","journal-title":"Hamostaseologie"},{"issue":"3","key":"10.1016\/j.bvth.2026.100209_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.2092","article-title":"Kynurenine is an endothelium-derived relaxing factor produced during inflammation","volume":"16","author":"Wang","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bvth.2026.100209_bib16","article-title":"Venous thrombosis assay in a mouse model of cancer","volume":"203","author":"Lotfollahzadeh","year":"2024","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.bvth.2026.100209_bib17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2017080929","article-title":"Uremic solute-aryl hydrocarbon receptor-tissue factor axis associates with thrombosis after vascular injury in humans","volume":"29","author":"Kolachalama","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100209_bib18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/4363","article-title":"Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation","volume":"20","author":"Wang","year":"2015","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","article-title":"Regulation of the immune response by the aryl hydrocarbon receptor","volume":"48","author":"Gutierrez-Vazquez","year":"2018","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bvth.2026.100209_bib20","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.chom.2023.09.008","article-title":"Maintaining a healthy balance: how endothelial AHR signaling helps regulate tissue homeostasis and protection","volume":"31","author":"Tat","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.bvth.2026.100209_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17080421","article-title":"Kynurenine promotes phosphate-induced endothelial calcification via endothelial-to-mesenchymal transition, osteoblastic differentiation and AhR activation","volume":"17","author":"Molinaro","year":"2025","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bvth.2026.100209_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9484217","article-title":"Kynurenine pathway metabolites as biomarkers in Alzheimer's disease","volume":"2022","author":"Liang","year":"2022","journal-title":"Dis Markers"},{"issue":"5","key":"10.1016\/j.bvth.2026.100209_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bvth.2026.100209_bib24","article-title":"Targeting von Willebrand factor selectively under inflammatory conditions","author":"Interlandi","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.bvth.2026.100209_bib25","article-title":"The IDO1\/AhR-HIF-1alpha metabolic axis: ARNT competition as a central antagonistic switch in autoimmune pathogenesis","volume":"17","author":"Dong","year":"2026","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100209_bib26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbamem.2010.05.016","article-title":"The resurgence of A2B adenosine receptor signaling","volume":"1808","author":"Aherne","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.bvth.2026.100209_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7150\/jca.31245","article-title":"Blockade of adenosine A2b receptor reduces tumor growth and migration in renal cell carcinoma","volume":"11","author":"Yi","year":"2020","journal-title":"J Cancer"},{"issue":"9","key":"10.1016\/j.bvth.2026.100209_bib28","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1158\/1078-0432.CCR-24-3934","article-title":"Adenosine A2B receptor promotes tumor progression and metastases in undifferentiated pleomorphic sarcoma","volume":"32","author":"Spalato Ceruso","year":"2026","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.bvth.2026.100209_bib29","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41416-020-0985-5","article-title":"Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia","volume":"123","author":"Craig","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s40425-019-0691-0","article-title":"miR-448 targets IDO1 and regulates CD8(+) T cell response in human colon cancer","volume":"7","author":"Lou","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-018-0600-x","article-title":"miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy","volume":"11","author":"Huang","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100209_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41418-020-00618-6","article-title":"Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment","volume":"28","author":"Zhou","year":"2021","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib33","article-title":"IDO family: the metabolic crossroads connecting immunity, nerves and tumors","volume":"24","author":"Wang","year":"2026","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.bvth.2026.100209_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100209_bib35","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/mp400677y","article-title":"Targeting to endothelial cells augments the protective effect of novel dual bioactive antioxidant\/anti-inflammatory nanoparticles","volume":"11","author":"Howard","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bvth.2026.100209_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.actbio.2026.04.030","article-title":"Engineering the mechano-biological properties of Zn(x)Fe(3-x)O(4) nanoparticles for enhanced stiffness-associated magneto-mechanical therapeutic performance","volume":"216","author":"Osuagwu","year":"2026","journal-title":"Acta Biomater"},{"key":"10.1016\/j.bvth.2026.100209_bib37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jconrel.2015.09.055","article-title":"Targeted endothelial nanomedicine for common acute pathological conditions","volume":"219","author":"Shuvaev","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.bvth.2026.100209_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/abp.2026.15740","article-title":"Advances in endothelial cell targeting by AAV vectors","volume":"73","author":"Cichon","year":"2026","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100209_bib39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2004-05-2042","article-title":"Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bvth.2026.100209_bib40","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Guideline Update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100209_bib41","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1038\/s41598-019-44039-z","article-title":"The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors","volume":"9","author":"He","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.bvth.2026.100209_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jth.14417","article-title":"Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells","volume":"17","author":"Kilani","year":"2019","journal-title":"J Thromb Haemost"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:25:54Z","timestamp":1791883554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000744"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100209","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial indoleamine 2,3-dioxygenase 1 drives high-tryptophan diet\u2013mediated thrombosis in cancer-bearing mice","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100209"}}